CD8A and classic Hodgkin lymphoma: Moreover, because the efficacy of PD-1 blockade in cHL mainly depends on CD4/MHC-II rather than CD8/MHC-I system [84], it seems reasonable that additional biological mechanisms may underlie the synergism between hypomethylating drugs and PD-1 blockade.